Dr. William E. Gillanders, MD

Dr. Gillanders practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Gillanders' NPI, 1720006364, was assigned on July 18, 2006. Dr. Gillanders graduated from Duke University School of Medicine in 1991. Dr. Gillanders holds Missouri license 2005001571.

Dr. Gillanders' primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Gillanders also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Gillanders' primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Gillanders is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Gillanders to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gillanders practices, 6 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Gillanders' primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Gillanders is licensed in Missouri.

CMS data shows 204 Medicare services from Dr. Gillanders across 5 procedure codes in 2024, for 150 Medicare patients. Medicare paid $54,300 for them.

CMS counts 150 Medicare patients who saw Dr. Gillanders in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gillanders' median patient age at 68, with 86% women.

In 2024, Dr. Gillanders wrote 54 Medicare Part D claims for 24 patients. 69% of them were for generic drugs. CMS names the drug for 37 of them, across 2 drugs with 11 or more claims each, at $430 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Gillanders for performance year 2024, reported as part of a group. Dr. Gillanders accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 91 papers to Dr. Gillanders, published from 2010 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Breast Neoplasms, Antigens, Neoplasm and Cancer Vaccines. Dr. Gillanders has published most often in Breast Cancer Res Treat. Dr. Gillanders' most frequent co-authors are Rebecca L. Aft, MD, Julie A. Margenthaler, MD and Amy Elizabeth Cyr, MD.

Dmand AI links Dr. Gillanders to 10 clinical trials, 6 of them phase 1 studies. 6 are still active or recruiting. Conditions studied include Breast Neoplasms, Pancreatic Neoplasms and Triple Negative Breast Neoplasms. Washington University School of Medicine sponsors the most, 7.

CMS Open Payments shows 11 general payments to Dr. Gillanders from 2 drug and device companies from 2018 to 2024. Travel and lodging make up the largest share, 67% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,443.

Dr. Gillanders graduated from Duke University School of Medicine in 1991.